Globe Life (NYSE:GL) CEO Frank Svoboda Sells 20,000 Shares of Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 20,000 shares of the stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Globe Life Stock Performance

GL opened at $156.97 on Wednesday. Globe Life Inc. has a 12-month low of $116.73 and a 12-month high of $157.92. The stock has a market cap of $12.19 billion, a price-to-earnings ratio of 10.86 and a beta of 0.50. The business has a 50 day moving average of $147.96 and a 200-day moving average of $142.31. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the business earned $3.07 earnings per share. The business’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities research analysts expect that Globe Life Inc. will post 15.57 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Institutional Trading of Globe Life

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Compound Planning Inc. grew its stake in Globe Life by 4.3% in the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after acquiring an additional 82 shares during the period. Root Financial Partners LLC grew its stake in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after acquiring an additional 83 shares during the period. Transcend Capital Advisors LLC grew its stake in Globe Life by 3.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after acquiring an additional 84 shares during the period. Natural Investments LLC grew its stake in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the period. Finally, Parallel Advisors LLC grew its stake in Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analyst Ratings Changes

GL has been the subject of a number of research reports. Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. Wells Fargo & Company raised their target price on shares of Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research note on Friday, April 10th. JPMorgan Chase & Co. raised their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Keefe, Bruyette & Woods restated a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Finally, Morgan Stanley lifted their price target on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, May 21st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $174.11.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.